Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
McKinsey
Novartis
Daiichi Sankyo
Medtronic
Farmers Insurance
Accenture
Moodys
Queensland Health

Generated: January 20, 2018

DrugPatentWatch Database Preview

ISOVUE-250 Drug Profile

« Back to Dashboard

Which patents cover Isovue-250, and when can generic versions of Isovue-250 launch?

Isovue-250 is a drug marketed by Bracco and is included in two NDAs.

The generic ingredient in ISOVUE-250 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for ISOVUE-250
Pharmacology for ISOVUE-250
Medical Subject Heading (MeSH) Categories for ISOVUE-250

US Patents and Regulatory Information for ISOVUE-250

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ISOVUE-250 iopamidol INJECTABLE;INJECTION 018735-007 Jul 6, 1992 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco ISOVUE-250 iopamidol INJECTABLE;INJECTION 020327-002 Oct 12, 1994 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
US Army
Farmers Insurance
Novartis
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot